Showing results (1311-1320 of 1,338) with videos related to
Sort By:
Pageof 134
Nature|December 6, 2019
The molecular landscape of ETMR at diagnosis and relapseSander Lambo, Susanne N Gröbner, Tobias Rausch, et al.Nature Genetics|February 9, 2026
A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classificationSybren L N Maas, Yiheng Tang, Eric Stutheit-Zhao, et al.Leukemia|May 6, 2021
Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomasDaniel Hübschmann, Kortine Kleinheinz, Rabea Wagener, et al.Nature Genetics|July 3, 2013
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytomaDavid T W Jones, Barbara Hutter, Natalie Jäger, et al.Nature|August 16, 2013
Signatures of mutational processes in human cancerLudmil B Alexandrov, Serena Nik-Zainal, David C Wedge, et al.Cancer Discovery|August 10, 2021
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence TargetsCornelis M van Tilburg, Elke Pfaff, Kristian W Pajtler, et al.Molecular Genetics and Metabolism|March 27, 2014
Phenylketonuria Scientific Review Conference: state of the science and future research needsKathryn M Camp, Melissa A Parisi, Phyllis B Acosta, et al.Cancer Cell|October 20, 2012
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastomaDominik Sturm, Hendrik Witt, Volker Hovestadt, et al.Cancer Cell|March 22, 2014
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibitionMarcel Kool, David T W Jones, Natalie Jäger, et al.Nature|December 21, 2017
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profilingStephen C Mack, Kristian W Pajtler, Lukas Chavez, et al.Pageof 134